AstraZeneca(US:AZN) Ge Long Hui·2026-01-14 09:20Group 1 - AstraZeneca (AZN.US) shares rose approximately 2% in pre-market trading following the announcement of its acquisition of biomedical AI company Modella AI [1] - The acquisition aims to expand the existing collaboration between AstraZeneca and Modella AI, focusing on the application of multimodal AI foundational models and AI agents in AstraZeneca's global oncology product portfolio [1] - Post-acquisition, Modella AI's generative and intelligent AI platform will be integrated into AstraZeneca's oncology drug development system, facilitating accelerated clinical development [1] Group 2 - AstraZeneca's closing price was $94.510, with a pre-market price of $96.1701, reflecting a 1.76% increase [2] - The company has a total market capitalization of $293.035 billion, with a total share count of 3.101 billion [2] - The stock has a price-to-earnings ratio of 42.00 and a price-to-book ratio of 6.385, indicating its valuation metrics [2]